Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449798 · ClinicalTrials.gov registry record · NA
Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT02449798 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 120 participants.
The verdict
NCT02449798, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Study objective is to evaluate user preference, time for procedure, insertion success rates, complications, completion of therapy and dwell time of the AccuCath 2.25" BC device placed in difficult IV access patients in the emergency department.
Interventions
- DEVICE AccuCath 2.25" BC Intravascular Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02449798
The ClinicalTrials.gov registry entry for NCT02449798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AccuCath 2.25" BC Intravascular Catheter is the first listed.
NCT02449798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02449798 about?
NCT02449798 is a clinical study titled "Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department". Study objective is to evaluate user preference, time for procedure, insertion success rates, complications, completion of therapy and dwell time of the AccuCath 2.25" BC device placed in difficult IV access patients in the emergency department.
What is the current status of trial NCT02449798?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02449798?
The interventions under investigation include: AccuCath 2.25" BC Intravascular Catheter (DEVICE).
Who is sponsoring clinical trial NCT02449798?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.